Company Overview of Lederle Laboratories
As of July 8, 2008 Lederle Laboratories went out of business. Lederle Laboratories manufactures vaccines. It makes pneumococcal vaccines approved for some adults and children ages 2. Lederle Laboratories was formerly known as Lederle Antitoxin Laboratories and changed its name to Lederle Laboratories following its acquisition by Wyeth Holdings Corporation. The company was founded in 1906 and is based in London, United Kingdom. Lederle Laboratories is a prior subsidiary of Wyeth Holdings Corporation.
1 More London Place
London, SE1 2AF
Founded in 1906
Key Executives for Lederle Laboratories
Lederle Laboratories does not have any Key Executives recorded.
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Lederle Laboratories, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.